Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tecnol v. Anago

This article was originally published in The Gray Sheet

Executive Summary

Federal District Court in Dallas rules that Tecnol is "not entitled to possess, directly or indirectly," rights to approximately 31% of Anago stock that Tecnol attempted to purchase in January 1992. In June, Tecnol sought court confirmation of its ownership of the stock ("The Gray Sheet" June 15, p. 23). Without the 533,000 disputed shares, Tecnol's stake in Anago is reduced to approximately 24%. Anago also is challenging Tecnol ownership of a "large" portion of the remaining stock, according to the company. In addition, Anago is seeking roughly $70 mil. in civil damages from Tecnol, alleging "tortious interference," breach of contract and civil conspiracy on the part of Tecnol. Remaining arguments in the dispute will be heard by the district court at a trial slated for September.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT000313

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel